November 24, 2008 Biederman J & J Risperdal DocumentsA group of internal emails by Johnson & Johnson officials-mostly from officials in the company’s Risperdal marketing Read More Biederman J & J Risperdal Documents
November 24, 2008 Biederman J & J Risperdal DocumentsThe New York Times reports (below) "Dr. Biederman’s work helped to fuel a 40-fold increase from 1994 Read More Biederman J & J Risperdal Documents
November 18, 2008 Antipsychotic Use in Children: FDA Panel Rejects FDA Soft-Peddle ApproachThe New York Times reports that an FDA advisory committee deliberating over the safety of using antipsychotic Read More Antipsychotic Use in Children: FDA Panel Rejects FDA Soft-Peddle Approach